---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-068733"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:16:33.345473+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics replaces auditor Mazars with Forvis Mazars effective June 1, 2024

## Summary
- Mazars USA LLP resigned after its partners and employees joined FORVIS LLP; the combined firm is now Forvis Mazars LLP.
- No adverse opinions, disagreements, or reportable events occurred in fiscal years 2022 or 2023 during Mazars' tenure.
- Audit committee appointed Forvis Mazars as new independent registered public accounting firm, subject to stockholder ratification.
- Mazars' letter to the SEC regarding the change is filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001104659-24-068733
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/0001104659-24-068733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/tm2416518d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-068733
- JSON: https://secwatch.observer/filing/0001104659-24-068733.json
- Plain text: https://secwatch.observer/filing/0001104659-24-068733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.